ATOS logo

ATOS
Atossa Therapeutics Inc

64,114
Mkt Cap
$111.51M
Volume
533,652.00
52W High
$1.66
52W Low
$0.5526
PE Ratio
-3.84
ATOS Fundamentals
Price
$0.8633
Prev Close
$0.8896
Open
$0.90
50D MA
$0.8915
Beta
1.22
Avg. Volume
1.35M
EPS (Annual)
-$0.2026
P/B
1.93
Rev/Employee
$0.00
Loading...
Loading...
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
15

Frequently Asked Questions

What is Market Cap of Atossa Therapeutics Inc?
What is the 52-week high for Atossa Therapeutics Inc?
What is the 52-week low for Atossa Therapeutics Inc?
What is Atossa Therapeutics Inc stock price today?
What was Atossa Therapeutics Inc stock price yesterday?
What is the PE ratio of Atossa Therapeutics Inc?
What is the Price-to-Book ratio of Atossa Therapeutics Inc?
What is the 50-day moving average of Atossa Therapeutics Inc?
How many employess does Atossa Therapeutics Inc has?

Latest ATOS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.